CAR T-cell therapy approval huge step for oncology, but only ‘beginning of story’ – Healio
Healio |
CAR T-cell therapy approval huge step for oncology, but only 'beginning of story'
Healio Tisagenlecleucel — the first CAR T-cell therapy to demonstrate early, deep and durable remission in patients with relapsed/refractory ALL — likely will become the new standard of care for this population, according to Stephan A. Grupp, MD, PhD, Yetta … |
